← Medtronic plc
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue |
$9.3b
+1.63%
|
$9.1b
-2.54%
|
$9.2b
+1.10%
|
$9.4b
+2.94%
|
$10.5b
+11.24%
|
$10.1b
-3.22%
|
$10.7b
+5.66%
|
$11.2b
+4.64%
|
$11.6b
+3.71%
|
$12.7b
+9.36%
|
$12.7b
0.00%
|
|
| Gross Profit |
$20.4b
+3.70%
|
$20.9b
+2.35%
|
$21.4b
+2.41%
|
$19.5b
-8.94%
|
$19.6b
+0.74%
|
$21.5b
+9.71%
|
$20.5b
-4.80%
|
$21.1b
+3.12%
|
$21.9b
+3.58%
|
$23.6b
+7.93%
|
$23.6b
0.00%
|
|
| Interest Income (Expense), Net | — | — | — | — | — | — | $386.0m |
$597.0m
+54.66%
|
$511.0m
-14.41%
|
$383.0m
-25.05%
|
— | |
| Selling, General and Administrative Expense | $9.7b | $10.0b | $10.4b | $10.1b | $10.1b | $10.3b | $10.4b | $10.7b | $10.8b | $11.8b | $11.8b | |
| Amortization of Intangible Assets | $2.0b | $1.8b | $1.8b | $1.8b | $1.8b | $1.7b | $1.7b | $1.7b | $1.8b | $1.8b | — | |
| Restructuring Costs | — | — | — | — | — | — | — | — | $303.0m | $370.0m | — | |
| Operating Income (Loss) |
$5.3b
+0.74%
|
$6.7b
+24.78%
|
$6.3b
-5.76%
|
$4.8b
-23.56%
|
$4.5b
-6.41%
|
$5.8b
+28.28%
|
$5.5b
-4.64%
|
$5.1b
-6.22%
|
$6.0b
+15.77%
|
$6.5b
+8.60%
|
$6.8b
+5.58%
|
|
| Other Operating Income (Expense), Net | $239.0m | $535.0m | ($258.0m) | ($71.0m) | ($315.0m) | ($862.0m) | $131.0m | ($464.0m) | $23.0m | ($386.0m) | — | |
| Interest Expense | $1.1b | $1.1b | $1.4b | $1.1b | $925.0m | $553.0m | $636.0m | $719.0m | — | — | $715.0m | |
| Interest Income, Other | $366.0m | $397.0m | — | — | — | — | — | — | — | — | — | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | — | — | — | — | ($140.0m) | — | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | — | — | — | — | — | — | — | ($220.0m) | ($171.0m) | — | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | — | — | — | — | — | — | — | ($57.0m) | — | |
| Gain (Loss) Related to Litigation Settlement | — | — | — | — | — | — | $30.0m | — | — | — | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $729.0m | $715.0m | $715.0m | |
| Other Nonoperating Income (Expense) | $313.0m | $181.0m | $373.0m | $356.0m | $336.0m | $318.0m | $515.0m | $412.0m | $402.0m | $384.0m | — | |
| Interest Income (Expense), Nonoperating, Net | ($728.0m) | ($749.0m) | $373.0m | $356.0m | $336.0m | $318.0m | $515.0m | $412.0m | $402.0m | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($234.0m) | ($958.0m) | $877.0m | $466.0m | ($358.0m) | $436.0m | $1.3b | $750.0m | $1.0b | $746.0m | $6.1b | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | — | — | — | $5.5b | $5.4b | $4.8b | $5.6b | $6.1b | $6.1b | |
| Current Income Tax Expense (Benefit) | $1.5b | $3.7b | $985.0m | $526.0m | $726.0m | $1.1b | $1.8b | $1.7b | $1.3b | $1.3b | $1.3b | |
| Income Tax Expense (Benefit) | $578.0m | $2.6b | $547.0m | ($751.0m) | $265.0m | $456.0m | $1.6b | $1.1b | $936.0m | $1.3b | $1.3b | |
| Net Income (Loss) Attributable to Parent |
$4.0b
+13.85%
|
$3.1b
-22.94%
|
$4.6b
+49.19%
|
$4.8b
+3.41%
|
$3.6b
-24.70%
|
$5.0b
+39.74%
|
$3.8b
-25.42%
|
$3.7b
-2.18%
|
$4.7b
+26.82%
|
$4.8b
+2.98%
|
$4.8b
0.00%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | ($4.0m) | ($9.0m) | $19.0m | $17.0m | $24.0m | $22.0m | $26.0m | $28.0m | $29.0m | $37.0m | $4.8b | |
| Earnings Per Share, Basic | $2.92 | $2.29 | $3.44 | $3.57 | $2.68 | $3.75 | $2.83 | $2.77 | $3.63 | $3.75 | $3.75 | |
| Earnings Per Share, Diluted | $2.89 | $2.27 | $3.41 | $3.54 | $2.66 | $3.73 | $2.82 | $2.76 | $3.61 | $3.73 | $3.73 | |
| Common Stock, Dividends, Per Share, Declared | $1.72 | $1.84 | $2.00 | $2.16 | $2.32 | $2.52 | $2.72 | $2.76 | $2.80 | $2.84 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 1.4b | 1.4b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | |
| Weighted Average Number of Shares Outstanding, Diluted | 1.4b | 1.4b | 1.4b | 1.4b | 1.4b | 1.4b | 1.3b | 1.3b | 1.3b | 1.3b | 1.3b | |
| Additional Financial Items | ||||||||||||
| Business Combination, Acquisition Related Costs | $230.0m | $132.0m | — | — | — | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | $0 | $0 | — | $0 | $0 | $0 | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.